Sign in Subscribe

GSK and Ionis Announce Major Win Against Hepatitis B in Landmark Trials

GSK and Ionis announce breakthrough results for bepirovirsen, a potential first-in-class treatment offering functional cure for chronic hepatitis B in just six months.

GSK and Ionis Announce Major Win Against Hepatitis B in Landmark Trials
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Already have an account? Sign in.